Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06273340 Effect on Evoked Pain in Healthy Volunteers
NCT02260947Phase 1Completed
- Sponsor
- Pfizer
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PF-06273340 in pain (5 arms), sponsored by Pfizer. Primary endpoints: Thermal pain detection threshold, Ultra-violet light sensitized pain detection threshold and 3 more. Started Oct 2014; status: completed.
02
Drugs
PF-06273340
03
Conditions
pain
Beyond the preview
Go deeper on NCT02260947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260947.